Sort by
Refine Your Search
-
Number: 6656749 Alnylam Pharmaceuticals-US Medical Affairs Postdoctoral Research Fellow About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a
-
therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust
-
accurate manner. Capture and analyze insights from healthcare professional inquiry trends to help inform medical affairs strategy and identify educational needs. Congress Strategy and Execution Gain hands
-
Number: 6623951 Alnylam Pharmaceuticals-Global Medical Information Postdoctoral Research Fellow About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships
-
precedent research to support regulatory strategy Support the development and lifecycle maintenance submissions for commercial programs Assist in the preparation of U.S. and/or international regulatory
-
. Additionally, the fellow will have the opportunity to attend meetings and conferences, present guidance reviews, and other opportunities as they arise. Key Responsibilities: Assist in the planning and
-
, developers, and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. BridgeBio exists to bring meaningful medicines to patients as quickly and as safely as
-
Number: 6563075 Apellis Pharmaceuticals-Global Medical Affairs Postdoctoral Research Fellow About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program
-
Number: 6563170 Intellia Therapeutics-Medical Affairs Postdoctoral Research Fellow About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a two
-
, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of